#pharmaceutical industry research
An easier way to understand the pharma industry
The main goal of the pharmaceutical industry is to provide drugs that prevent infections, maintain health, and cure diseases. This industry directly affects the global population, so a number of international regulatory bodies monitor things like drug safety, patents, quality, and pricing. Here are some of those regulatory entities:
- World Health Organization (or WHO)
- US Food and Drug Administration (or FDA)
- Medicines and Healthcare Products Regulatory Agency (or MHRA)
The pharmaceutical industry has made a great deal of progress over the last decade due to a research-oriented approach that has improved technologies, developed infrastructures, and increased research in the field of bioscience. Thanks to biotechnology, various formulations have been developed to cure or stop the growth of several major infections, including HIV and certain types of cancer.
The global pharmaceutical industry was worth an estimated $1 trillion in 2014. In 2013, global pharmaceutical markets generated revenues of $980.1 billion. That year, North America (the US and Canada) contributed 41% of sales, while Europe contributed 27.4%.
Publicly traded companies and ETFs
In the drug manufacturing category, the major publicly traded companies include Johnson Johnson, Novartis AG (NVS ), Pfizer Inc. (PFE ), Merck, Sanofi, and GlaxoSmithKline.
Gilead Sciences Inc. Amgen Inc. (AMGN ), Celgene Corporation (CELG ), Biogen Idec Inc. and Regeneron Pharmaceuticals Inc. are the major publicly traded biotechnology companies.
Pharmaceutical ETFs include the PowerShares Dynamic Pharmaceuticals ETF (PJP ), the SPDR S P Pharmaceuticals ETF, the iShares US Pharmaceuticals ETF, the iShares NASDAQ Biotechnology ETF, and the VanEck Vectors Pharmaceutical ETF.